CARLA M OBERMEYER

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi The consequences of female circumcision for health and sexuality: an update on the evidence
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, Boston, MA 02115, USA
    Cult Health Sex 7:443-61. 2005
  2. ncbi Symptoms, menopause status, and country differences: a comparative analysis from DAMES
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, Boston, MA, USA
    Menopause 14:788-97. 2007
  3. ncbi The menopause in Spain: results of the DAMES (Decisions At MEnopause) study
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, 655 Avenue of the Arts, Boston, MA 02115, USA
    Maturitas 52:190-8. 2005
  4. ncbi Therapeutic decisions for menopause: results of the DAMES project in central Massachusetts
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard School of Public Health, 665 Avenue of the Arts, Boston, MA, USA
    Menopause 11:456-65. 2004
  5. ncbi Menopause in Morocco: symptomatology and medical management
    Carla Makhlouf Obermeyer
    Department of Gender and Women's Health, Harvard University, 665 Avenue of the Arts, Boston, MA 02115, USA
    Maturitas 41:87-95. 2002
  6. ncbi Cross-cultural comparisons: midlife, aging, and menopause
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, Cambridge, MA, USA
    Menopause 14:663-7. 2007
  7. ncbi The health consequences of female circumcision: science, advocacy, and standards of evidence
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, USA
    Med Anthropol Q 17:394-412. 2003
  8. ncbi Women's midlife health across cultures: DAMES comparative analysis
    Michelle A Parsons
    Department of Anthropology, Emory University, Atlanta, GA 30322, USA
    Menopause 14:760-8. 2007
  9. ncbi Symptom groupings at midlife: cross-cultural variation and association with job, home, and life change
    Lynnette Leidy Sievert
    Department of Anthropology, University of Massachusetts Amherst, Amherst, MA 01003 9278, USA
    Menopause 14:798-807. 2007
  10. ncbi Determinants of hot flashes and night sweats
    Lynnette Leidy Sievert
    Department of Anthropology, UMass Amherst, MA 01003 9278, USA
    Ann Hum Biol 33:4-16. 2006

Detail Information

Publications17

  1. ncbi The consequences of female circumcision for health and sexuality: an update on the evidence
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, Boston, MA 02115, USA
    Cult Health Sex 7:443-61. 2005
    ....
  2. ncbi Symptoms, menopause status, and country differences: a comparative analysis from DAMES
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, Boston, MA, USA
    Menopause 14:788-97. 2007
    ....
  3. ncbi The menopause in Spain: results of the DAMES (Decisions At MEnopause) study
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, 655 Avenue of the Arts, Boston, MA 02115, USA
    Maturitas 52:190-8. 2005
    ..To assess the symptomatology of menopause and the use of hormone therapy among women in Spain...
  4. ncbi Therapeutic decisions for menopause: results of the DAMES project in central Massachusetts
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard School of Public Health, 665 Avenue of the Arts, Boston, MA, USA
    Menopause 11:456-65. 2004
    ....
  5. ncbi Menopause in Morocco: symptomatology and medical management
    Carla Makhlouf Obermeyer
    Department of Gender and Women's Health, Harvard University, 665 Avenue of the Arts, Boston, MA 02115, USA
    Maturitas 41:87-95. 2002
    ..CONCLUSIONS: Reports of hot flashes and joint pains are relatively high, but the frequency of use of medical services for menopause is low...
  6. ncbi Cross-cultural comparisons: midlife, aging, and menopause
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, Cambridge, MA, USA
    Menopause 14:663-7. 2007
    ..This multidisciplinary collection of papers is an impressive commentary on what has been done in cross-cultural research and a compendium of suggestions for the future...
  7. ncbi The health consequences of female circumcision: science, advocacy, and standards of evidence
    Carla Makhlouf Obermeyer
    Department of Population and International Health, Harvard University, USA
    Med Anthropol Q 17:394-412. 2003
    ....
  8. ncbi Women's midlife health across cultures: DAMES comparative analysis
    Michelle A Parsons
    Department of Anthropology, Emory University, Atlanta, GA 30322, USA
    Menopause 14:760-8. 2007
    ..The Decisions At Menopause Study (DAMES) investigates the experience of menopause in four countries. This article explores self-reported health...
  9. ncbi Symptom groupings at midlife: cross-cultural variation and association with job, home, and life change
    Lynnette Leidy Sievert
    Department of Anthropology, University of Massachusetts Amherst, Amherst, MA 01003 9278, USA
    Menopause 14:798-807. 2007
    ..To examine how symptoms at midlife grouped together by factor analyses in four different countries and to examine whether life changes were associated with symptom frequencies...
  10. ncbi Determinants of hot flashes and night sweats
    Lynnette Leidy Sievert
    Department of Anthropology, UMass Amherst, MA 01003 9278, USA
    Ann Hum Biol 33:4-16. 2006
    ..The purpose of this study was to identify determinants of hot flashes and night sweats, two vasomotor symptoms associated with the hormonal changes of the menopause transition...
  11. ncbi Age at natural menopause in Spain and the United States: results from the DAMES project
    Robert F Reynolds
    Pfizer, Inc, Global Epidemiology, 150 East 42nd Street, MS 150 3 72, New York, New York 10017, USA
    Am J Hum Biol 17:331-40. 2005
    ..S. are comparable to other industrialized nations. The factors associated with the timing of natural menopause, in particular smoking and BMI, are consistent with those identified in previous studies...
  12. ncbi The medical management of menopause: a four-country comparison care in urban areas
    Lynnette Leidy Sievert
    Department of Anthropology, UMass Amherst, 240 Hicks Way, Amherst, MA 01003 9278, USA
    Maturitas 59:7-21. 2008
    ..To compare the medical management of menopause across urban areas in four countries which differ by level of income and degree of medicalization...
  13. ncbi HIV in the Middle East
    Carla Makhlouf Obermeyer
    Department of HIV/AIDS, World Health Organization, Geneva, 1211, Switzerland
    BMJ 333:851-4. 2006
  14. ncbi Reframing research on sexual behavior and HIV
    Carla Makhlouf Obermeyer
    Department of HIV, World Health Organization, 20 Avenue Appia, 1211 Geneva, Switzerland
    Stud Fam Plann 36:1-12. 2005
    ..They show that expanding the models that drive research in this area is possible, and that efforts to combine disciplinary perspectives result in deeper understandings of knowledge, risk perceptions, attitudes, and behavioral change...
  15. ncbi HAART and sexual risk behavior
    Carla Makhlouf Obermeyer
    JAMA 292:2335; author reply 2336. 2004
  16. ncbi The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy
    Robert F Reynolds
    Safety Evaluation and Epidemiology, Pfizer, Inc, 235 East 42nd Street, MS 150 3 72, New York, NY 10017, USA
    Maturitas 43:183-94. 2002
    ....
  17. ncbi Medication use and gender in Massachusetts: results of a household survey
    Carla Makhlouf Obermeyer
    World Health Organization, Geneva, Switzerland
    Health Care Women Int 28:593-613. 2007
    ..Responses to open-ended questions suggest that women's discourse about the effect of medications differs from men's in terms of the range and detail of descriptions of symptoms and side effects...